Snowball logo
logo
1857

Chong Kun Dang Pharmaceutical

185750 β€’ KO
β‚©68,200.00-β‚©900.00Β  (1.3%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
1,343,559.41,488,344.71,669,404.41,586,430.81,692,4041,739,213.8
COGS
847,741.1945,705.31,007,202.91,053,819.61,166,026.11,212,250
Gross Profit
495,818.3542,639.4662,201.5532,611.2526,377.9526,963.8
Operating Expenses & Income
Operating Income
94,758.7109,906.1246,599.399,461.580,567.782,202.3
Total Operating Expenses
1,248,800.71,378,438.71,422,805.21,486,969.21,611,836.31,657,011.5
R&D Expenses
163,276.7176,324.9140,234.5143,914.3154,097.1152,472.8
Selling General & Admin Expenses
102,713.9116,451.1131,375.8139,961.9142,465.6141,164.1
Earnings from Continuing Operations
Interest Expense
(4,029.9)(6,846.9)(9,271)(8,319)(6,699.5)(7,147.3)
Interest Income
716.22,1395,789.312,4106,919.86,604.2
Income Tax Expense
38,237.417,187.3----
Net Income
Net Income
42,720.480,953.4212,521.2109,072.877,508.578,547.2
Supplemental
EBIT
94,758.7109,906.1----
EBITDA
112,105.6137,609.7----
In millions of KRW, except % and values per 1 share